Trials / Terminated
TerminatedNCT00893516
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Emergent BioSolutions · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CHOP + CD4 | |
| DRUG | CHOP |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-10-01
- Completion
- 2008-12-01
- First posted
- 2009-05-06
- Last updated
- 2024-04-09
- Results posted
- 2021-04-21
Source: ClinicalTrials.gov record NCT00893516. Inclusion in this directory is not an endorsement.